U.S Class(es): 005, 006, 018, 044, 046, 051, 052
Class Status: Active
Name | Novartis Pharma AG, |
---|---|
Address | Trademark Department Postfach CH-4002 Basel SWITZERLAND |
Date | Description | Action Tags | Code |
---|---|---|---|
Sep-02-2021 | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | SDRCM | |
Sep-09-2021 | LIMITATION FROM ORIGINAL APPLICATION ENTERED | LIMII | |
Sep-13-2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | NWOSI | |
Sep-17-2021 | APPLICATION FILING RECEIPT MAILED | MAFRO | |
Oct-19-2021 | ASSIGNED TO EXAMINER | DOCKD | |
Oct-26-2021 | APPROVED FOR PUB - PRINCIPAL REGISTER | CNSAO | |
Nov-10-2021 | NOTICE OF PUBLICATION | NPUBO | |
Nov-17-2021 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | OP2RP | |
Nov-17-2021 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | OPNSP | |
Nov-30-2021 | PUBLISHED FOR OPPOSITION | PUBOA | |
Dec-12-2021 | NOTIFICATION PROCESSED BY IB | GPNXP | |
Dec-22-2021 | INTERNATIONAL REGISTRATION RENEWED | RNWLP | |
Feb-15-2022 | REGISTERED-PRINCIPAL REGISTER | R.PRA | |
Mar-17-2022 | GRANT OF PROTECTION CREATED, TO BE SENT TO IB | GPARP | |
Jun-03-2022 | FINAL DISPOSITION PROCESSED | FIMPP | |
Jun-04-2022 | FINAL DISPOSITION NOTICE SENT TO IB | FICSP | |
Jul-04-2022 | NOTIFICATION PROCESSED BY IB | GPNXP |